STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA

BioNTech and Pfizer presented bispecifics data at the ASCO annual meeting. FDA's Pazdur highlighted a positive outlook despite challenges. The article is part of STAT+'s coverage of the event.